Oral Cenerimod Effective in Reducing Gland Inflammation in Mouse Models

Oral Cenerimod Effective in Reducing Gland Inflammation in Mouse Models

315985

Oral Cenerimod Effective in Reducing Gland Inflammation in Mouse Models

The experimental oral therapy cenerimod prevented immune cells from entering the salivary glands and reduced gland inflammation in two Sjögren’s syndrome mouse models, a study demonstrated. “These encouraging data suggest that cenerimod may be a promising approach to treating Sjögren’s syndrome,” the scientists said. The study, titled “Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome” and funded by Idorsia Pharmaceuticals, was published in the journal Arthritis Research…

You must be logged in to read/download the full post.